Queensland University of Technology Translational Research Institute

The Translational Research Institute (TRI) is a leading Australian medical research facility based in Brisbane, designed to accelerate the translation of scientific discoveries into clinical applications. It is a unique joint venture between the University of Queensland, Queensland University of Technology, Mater Research, and Metro South Health. TRI provides a bench-to-bedside environment, housing over 1,000 researchers and clinicians alongside state-of-the-art core facilities and a clinical trials center. The institute focuses on diverse therapeutic areas including oncology, immunology, and chronic diseases, and features a dedicated biopharmaceutical manufacturing facility operated by Thermo Fisher Scientific. This integration of research, clinical trials, and manufacturing makes TRI a critical hub for biotechnology innovation in the Southern Hemisphere.